|
US6204261B1
(en)
|
1995-12-20 |
2001-03-20 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β Converting enzyme inhibitors
|
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
WO1991015577A1
(en)
|
1990-04-04 |
1991-10-17 |
Black, Roy, A. |
INTERLEUKIN 1'beta' PROTEASE
|
|
DE69226820T2
(de)
|
1991-06-21 |
1999-05-12 |
Merck & Co., Inc., Rahway, N.J. |
Peptidylderivate als Inhibitoren von Interleukin-1B-konvertierenden Enzymen
|
|
AU657701B2
(en)
|
1991-08-30 |
1995-03-23 |
Vertex Pharmaceuticals Incorporated |
Interleukin 1beta protease and interleukin 1beta protease inhibitors
|
|
GB9123326D0
(en)
|
1991-11-04 |
1991-12-18 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
|
WO1993012076A1
(en)
|
1991-12-13 |
1993-06-24 |
Corvas International Inc. |
Reagents for automated synthesis of peptide analogs
|
|
AU3479593A
(en)
|
1992-01-31 |
1993-09-01 |
Merck & Co., Inc. |
Peptidyl derivatives as inhibitors of interleukin-1beta converting enzyme
|
|
AU3666893A
(en)
|
1992-02-21 |
1993-09-13 |
Merck & Co., Inc. |
Peptidyl derivatives as inhibitors of interleukin-1beta converting enzyme
|
|
FR2698984B1
(fr)
|
1992-12-04 |
1995-01-06 |
Commissariat Energie Atomique |
Procédé et dispositif d'acquisition d'une image à trois dimensions d'un petit objet par palpage lumineux et moyen d'étalonnage pour la mise en Óoeuvre d'une telle acquisition.
|
|
CN1504462A
(zh)
|
1994-03-31 |
2004-06-16 |
������˹ҩƷ��˾ |
作为白细胞介素抑制剂的嘧啶基衍生物
|
|
US5552400A
(en)
|
1994-06-08 |
1996-09-03 |
Sterling Winthrop Inc. |
Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors
|
|
US5716929A
(en)
|
1994-06-17 |
1998-02-10 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of interleukin-1β converting enzyme
|
|
US5565430A
(en)
|
1994-08-02 |
1996-10-15 |
Sterling Winthrop Inc. |
Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors
|
|
CA2215211A1
(en)
|
1995-03-31 |
1996-10-03 |
Takeda Chemical Industries, Ltd. |
Cysteine protease inhibitor
|
|
US5798442A
(en)
|
1995-04-21 |
1998-08-25 |
Merck Frosst Canada, Inc. |
Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases
|
|
US5744451A
(en)
|
1995-09-12 |
1998-04-28 |
Warner-Lambert Company |
N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
|
|
EP0761680A3
(en)
|
1995-09-12 |
1999-05-06 |
Ono Pharmaceutical Co., Ltd. |
Tetrazole compounds having Interleukin-1beta converting enzyme inhibitory activity
|
|
AU3359697A
(en)
|
1996-07-08 |
1998-02-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Bone resorption inhibitors
|
|
US6610683B2
(en)
|
1996-09-12 |
2003-08-26 |
Idun Pharmaceuticals, Inc. |
Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
|
AU738048B2
(en)
|
1996-09-12 |
2001-09-06 |
Idun Pharmaceuticals, Inc. |
Inhibition of apoptosis using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitors
|
|
US6531467B2
(en)
|
1996-09-12 |
2003-03-11 |
Idun Pharmaceuticals, Inc. |
Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
|
US6200969B1
(en)
|
1996-09-12 |
2001-03-13 |
Idun Pharmaceuticals, Inc. |
Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
|
US5968927A
(en)
|
1996-09-20 |
1999-10-19 |
Idun Pharmaceuticals, Inc. |
Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes
|
|
NZ334887A
(en)
|
1996-10-11 |
2000-09-29 |
Basf Ag |
Sulfonamide substituted aspartic acid interleukin-1'beta' converting enzyme inhibitors
|
|
CA2268086A1
(en)
|
1996-10-11 |
1998-04-23 |
Warner-Lambert Company |
Sulfonamide interleukin-1.beta. converting enzyme inhibitors
|
|
AU738341B2
(en)
|
1996-10-11 |
2001-09-13 |
Abbott Gmbh & Co. Kg |
Asparate ester inhibitors of interleukin-1beta converting enzyme
|
|
US5919790A
(en)
|
1996-10-11 |
1999-07-06 |
Warner-Lambert Company |
Hydroxamate inhibitors of interleukin-1β converting enzyme
|
|
US6184244B1
(en)
|
1996-12-16 |
2001-02-06 |
Idun Pharmaceuticals, Inc. |
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
US6184210B1
(en)
|
1997-10-10 |
2001-02-06 |
Cytovia, Inc. |
Dipeptide apoptosis inhibitors and the use thereof
|
|
PT1049703E
(pt)
|
1998-01-20 |
2003-06-30 |
Warner Lambert Co |
Aldeido do acido n-¬2-(5-benziloxicarbonilamino-6-oxo-2-(4-fluorofenil)-1,6-di-hidro-1-pirimidinil)acetoxil|-l-aspartico como inibidor da enzima de conversao da interleucina-1beta in vivo
|
|
KR20010041905A
(ko)
|
1998-03-16 |
2001-05-25 |
시토비아 인크. |
디펩티드 카스파제 억제제 및 이의 용도
|
|
TWI243828B
(en)
|
1998-03-19 |
2005-11-21 |
Vertex Pharma |
Inhibitors of caspases
|
|
ES2242394T3
(es)
|
1998-05-05 |
2005-11-01 |
Warner-Lambert Company Llc |
Inhibidores de tipo succinamida de la enzima convertidora de la interleuquina 1 beta.
|
|
US6197750B1
(en)
|
1998-07-02 |
2001-03-06 |
Idun Pharmaceuticals, Inc. |
C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
US6242422B1
(en)
|
1998-10-22 |
2001-06-05 |
Idun Pharmacueticals, Inc. |
(Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
US6391575B1
(en)
|
1999-03-05 |
2002-05-21 |
Idun Pharmaceuticals, Inc. |
Methods for detecting membrane derived caspase activity and modulators thereof
|
|
JP2002539193A
(ja)
|
1999-03-16 |
2002-11-19 |
メルク フロスト カナダ アンド カンパニー |
カスパーゼ−３阻害薬としてのγ−ケト酸ジペプチド類
|
|
AU3876600A
(en)
|
1999-03-16 |
2000-10-04 |
Cytovia, Inc. |
Substituted 2-aminobenzamide caspase inhibitors and the use thereof
|
|
US6355618B1
(en)
|
1999-04-09 |
2002-03-12 |
Cytovia, Inc. |
Caspase inhibitors and the use thereof
|
|
ATE344249T1
(de)
|
1999-07-19 |
2006-11-15 |
Merck Frosst Canada Ltd |
Pyrazinone, diese verbindungen enthaltende zusammenstellungen
|
|
DE60010675T2
(de)
|
1999-08-06 |
2005-06-16 |
Vertex Pharmaceuticals Inc., Cambridge |
Caspase inhibitoren und deren verwendung
|
|
US6495522B1
(en)
|
1999-08-27 |
2002-12-17 |
Cytovia, Inc. |
Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
|
|
US6566338B1
(en)
|
1999-10-12 |
2003-05-20 |
Cytovia, Inc. |
Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death
|
|
AR026748A1
(es)
|
1999-12-08 |
2003-02-26 |
Vertex Pharma |
Un compuesto inhibidor de caspasas, una composicion farmaceutica que lo comprende, un metodo para la sintesis del mismo y un compuesto intermediario paradicha sintesis
|
|
AU2001249619B2
(en)
|
2000-03-29 |
2006-08-17 |
Vertex Pharmaceuticals Incorporated |
Carbamate caspase inhibitors and uses thereof
|
|
PE20011350A1
(es)
|
2000-05-19 |
2002-01-15 |
Vertex Pharma |
PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
|
|
KR20020025959A
(ko)
|
2000-05-23 |
2002-04-04 |
버텍스 파마슈티칼스 인코포레이티드 |
카스파제 억제제 및 이의 용도
|
|
WO2001094351A1
(en)
|
2000-06-07 |
2001-12-13 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
|
CA2315468A1
(en)
|
2000-08-10 |
2002-02-10 |
Thermax International Corp. |
Multi grouting system
|
|
CA2418720A1
(en)
|
2000-09-13 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
|
DE60127860T2
(de)
|
2000-11-21 |
2008-01-17 |
Vertex Pharmaceuticals Inc., Cambridge |
Imidazol- und benzimidazol- caspase inhibitoren und deren verwendung
|
|
US20030096737A1
(en)
|
2001-04-19 |
2003-05-22 |
Anita Diu-Hercend |
Caspase inhibitors and uses thereof
|
|
CA2445923A1
(en)
|
2001-05-10 |
2002-11-14 |
Abbott Gmbh & Co. Kg |
Arylsulfonamide ethers, and methods of use thereof
|
|
WO2002094263A2
(en)
|
2001-05-23 |
2002-11-28 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
|
JP2005509028A
(ja)
|
2001-10-09 |
2005-04-07 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
アスパラギン酸およびグルタミン酸誘導体ならびにそのジアゾケトン中間体を合成するための方法
|
|
WO2003072528A2
(en)
|
2002-02-08 |
2003-09-04 |
Idun Pharmaceuticals, Inc. |
(substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
US7410956B2
(en)
|
2002-02-11 |
2008-08-12 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitor prodrugs
|
|
GB0203446D0
(en)
*
|
2002-02-14 |
2002-04-03 |
Univ Lancaster |
Detection and/or monitoring of synuclein-related diseases
|
|
AU2003272189A1
(en)
|
2002-04-05 |
2004-01-19 |
Cytovia, Inc. |
Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents
|
|
US7138395B2
(en)
|
2002-06-10 |
2006-11-21 |
The Procter & Gamble Company |
Interleukin-1β converting enzyme inhibitors
|
|
US7001899B2
(en)
|
2002-06-10 |
2006-02-21 |
The Procter & Gamble Company |
Interleukin converting enzyme inhibitors
|
|
US7041696B2
(en)
|
2002-06-17 |
2006-05-09 |
The Procter & Gamble Company |
Interleukin-1β converting enzyme inhibitors
|
|
PL374598A1
(en)
|
2002-06-28 |
2005-10-31 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
|
US7612091B2
(en)
|
2002-12-20 |
2009-11-03 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
|
US7521481B2
(en)
|
2003-02-27 |
2009-04-21 |
Mclaurin Joanne |
Methods of preventing, treating and diagnosing disorders of protein aggregation
|
|
PL2361928T3
(pl)
*
|
2003-05-19 |
2017-09-29 |
Prothena Biosciences Limited |
Skrócone fragmenty alfa-synukleiny w chorobie z ciałami Lewy'ego
|
|
AU2004253967B2
(en)
|
2003-07-03 |
2010-02-18 |
Cytovia, Inc. |
4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
|
|
WO2005047860A2
(en)
|
2003-11-08 |
2005-05-26 |
Elan Pharmaceuticals, Inc. |
Antibodies to alpha-synuclein
|
|
US20050202508A1
(en)
|
2003-11-12 |
2005-09-15 |
Pasinetti Guilio M. |
Biomarker for Parkinson's disease
|
|
WO2005113523A1
(en)
|
2004-05-20 |
2005-12-01 |
Foldrx Pharmaceuticals, Inc. |
2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
|
|
CA2567080A1
(en)
|
2004-05-27 |
2005-12-15 |
Vertex Pharmaceuticals Incorporated |
Ice inhibitors for the treatment of autoinflammatory diseases
|
|
CA2580767A1
(en)
|
2004-09-17 |
2006-03-30 |
Whitehead Institute For Biomedical Research |
Compounds, compositions and methods of inhibiting alpha-synuclein toxicity
|
|
WO2006086517A2
(en)
|
2005-02-08 |
2006-08-17 |
The Scripps Research Institute |
Inhibitors of transthyretin amyloid fibril formation
|
|
US20070092889A1
(en)
|
2005-06-02 |
2007-04-26 |
Perlegen Sciences, Inc. |
Parkinson's disease-related disease compositions and methods
|
|
CA2640454A1
(en)
|
2006-01-26 |
2007-08-09 |
Foldrx Pharmaceuticals, Inc. |
Compounds and methods for modulating protein trafficking
|
|
US20070197453A1
(en)
|
2006-02-17 |
2007-08-23 |
Mclaurin Joanne |
Compositions and methods for treatment of disorders of protein aggregation
|
|
WO2008034016A2
(en)
|
2006-09-15 |
2008-03-20 |
Foldrx Pharmaceuticals, Inc. |
Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins
|
|
EP2155226A4
(en)
|
2007-06-14 |
2010-07-28 |
Univ California |
COMPOUNDS FOR INHIBITING THE PROTEIN AGGREGATION AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
WO2010003092A1
(en)
|
2008-07-03 |
2010-01-07 |
University Of Massachusetts |
Methods and compositions for reducing inflammation and treating inflammatory disorders
|
|
US20120276019A1
(en)
*
|
2008-07-25 |
2012-11-01 |
Diamedica Inc. |
Tissue kallikrein for the treatment of parkinson's disease
|
|
WO2010054127A1
(en)
|
2008-11-05 |
2010-05-14 |
Elan Pharmaceuticals, Inc. |
Methods and agents for stabilizing non-pathological amyloidogenic polypeptides
|
|
CN102317316B
(zh)
*
|
2008-12-19 |
2014-08-13 |
帕尼玛制药股份公司 |
人抗α突触核蛋白自身抗体
|
|
WO2012061789A2
(en)
*
|
2010-11-05 |
2012-05-10 |
Brandeis University |
Tetrameric alpha-synuclein and use thereof
|
|
WO2012061786A1
(en)
*
|
2010-11-05 |
2012-05-10 |
Brandeis University |
Ice cleaved alpha-synuclein a biomarker
|